ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselEsoCap AG
EsoCap AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

EsoCap AG is a clinical-stage biotechnology company developing a platform for targeted drug delivery to the esophagus. Its system uses a capsule to apply a drug-loaded mucoadhesive film to the esophageal lining; its candidate ESO-101 was studied in a Phase II trial for eosinophilic esophagitis.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
✓ Offered3
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

EsoCap AG

Esophageal Drug Delivery Platform
Targeted, long-lasting local application of active substances to the esophagus; capsule-with-film system with mucoadhesive film release and prolonged mucosal contact time.
Lead Indication Development for Eosinophilic Esophagitis
Clinical development of ESO-101 for eosinophilic esophagitis; ACESO Phase II study with mometasone, including safety, tolerability and efficacy data.
Partnering for Development and Manufacturing
Partnerships with biopharma companies, universities and CDMOs for industrial development, manufacture of clinical trial samples and further platform applications.
Trust & reputation

ranQ Trust Score of EsoCap AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of November 2026

Without public customer reviews the score stays capped.

EsoCap AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
EsoCap AG scores 82.0 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.83.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
EsoCap AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
EsoCap AG scores 26.5 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.42.94%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

EsoCap AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

November 24, 2021Media
EsoCap obtains funding as Phase II study progresses
startupticker.ch

Knowledge

No knowledge articles yet

Once EsoCap AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

EsoCap AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank EsoCap AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of EsoCap AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Malzgasse 9
4052 Basel

At a glance

Legal form
Corporation
UID
CHE-467.535.992
Founded
2017 · 9 years
Last commercial register change
July 7, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    TT
    Tenpoint Therapeutics GmbH
    Basel
    LT
    LifeMine Therapeutics (Switzerland) GmbH
    Basel
    LG
    Lonza Group AG
    Basel
    GA
    Galvita AG
    Basel
    HP
    Hengrui Pharmaceuticals Europe AG
    Basel
    DG
    DrugRekindle GmbH
    Basel
    TH
    ten23 Health AG
    Basel
    AP
    Arakena Pharmaceuticals AG
    Basel